{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T05:40:39Z","timestamp":1792215639794,"version":"4.4.0"},"reference-count":32,"publisher":"Japan Atherosclerosis Society","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2026]]},"DOI":"10.5551\/jat.66328","type":"journal-article","created":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:10:08Z","timestamp":1792015808000},"source":"Crossref","is-referenced-by-count":0,"title":["Differential Effects of Direct Plasmin Inhibition and Tranexamic Acid on Atherosclerosis Progression and Vascular Remodeling in Apoe\/Ldlr Double-Knockout Mice"],"prefix":"10.5551","author":[{"given":"Natsumi","family":"Yoshihama","sequence":"first","affiliation":[{"name":"Laboratory of Medical Technology, Faculty of Nutrition, Kobe Gakuin University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nana","family":"Kurisu","sequence":"additional","affiliation":[{"name":"Laboratory of Medical Technology, Faculty of Nutrition, Kobe Gakuin University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Shimatani","sequence":"additional","affiliation":[{"name":"Laboratory of Medical Technology, Faculty of Nutrition, Kobe Gakuin University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanae","family":"Hyodo","sequence":"additional","affiliation":[{"name":"Laboratory of Medical Technology, Faculty of Nutrition, Kobe Gakuin University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naotaka","family":"Ohta","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory Science, Faculty of Health Care, Tenri University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromitsu","family":"Ishii","sequence":"additional","affiliation":[{"name":"Laboratory of Medical Technology, Faculty of Nutrition, Kobe Gakuin University"},{"name":"Medical Corporation, Jinkeikai Ishii Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Laboratory of Medical Technology, Faculty of Nutrition, Kobe Gakuin University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Ansari HUH, Mahboob E, Samad MA, Shahzad M, Ahmed M, Naqvi STH, Qazi SU, Ahmed F, Ross-Kenny H, Baniowda M, Farrukh H, Ahmed R: Temporal trends and disparities in atherosclerosis-associated cerebrovascular disease mortality in the United States, 1999-2020. Curr Probl Cardiol, 2025; 50: 102935","DOI":"10.1016\/j.cpcardiol.2024.102935"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Bay B, Blaum C, Kellner C, Bei der Kellen R, Ojeda F, Waibel J, Arnold N, Behrendt CA, Rimmele DL, Thomalla G, Twerenbold R, Blankenberg S, Zyriax B, Brunner FJ, Waldeyer C: Inflammatory burden, lifestyle, and atherosclerotic cardiovascular disease: insights from a population-based cohort study. Sci Rep, 2023; 13: 21761","DOI":"10.1038\/s41598-023-48602-7"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Morrison AM, Sullivan AE, Aday AW: Atherosclerotic Disease: Pathogenesis and Approaches to Management. Med Clin North Am, 2023; 107: 793-805","DOI":"10.1016\/j.mcna.2023.04.004"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Khouzaz HB, Ji Y, Braet DJ, Vadali M, Abdelhamid AA, Emal CD, Lawrence DA, Fay WP: Drug Targeting of Plasminogen Activator Inhibitor-1 Inhibits Metabolic Dysfunction and Atherosclerosis in a Murine Model of Metabolic Syndrome. Arterioscler Thromb Vasc Biol, 2020; 40: 1479-1490","DOI":"10.1161\/ATVBAHA.119.313775"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Furumoto T, Fujii S, Nishihara K, Yamada S, Komuro K, Goto K, Onozuka H, Mikami T, Kitabatake A, Sobel BE: Maladaptive arterial remodeling with systemic hypertension associated with increased concentrations in blood of plasminogen activator inhibitor type-1 (PAI-1). Am J Cardiol, 2004; 93: 997-1001","DOI":"10.1016\/j.amjcard.2003.12.053"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Rezaee F, Gijbels M, Offerman E, Verheijen J: Genetic deletion of tissue-type plasminogen activator (t-PA) in APOE3-Leiden mice reduces progression of cholesterol-induced atherosclerosis. Thromb Haemost, 2003; 90: 710-716","DOI":"10.1160\/TH03-03-0160"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Larmann J, Jurk K, Janssen H, Muller M, Herzog C, Lorenz A, Schmitz M, Nofer JR, Theilmeier G: Hepatic overexpression of soluble urokinase receptor (uPAR) suppresses diet-induced atherosclerosis in low-density lipoprotein receptor-deficient (LDLR-\/-) mice. PLoS One, 2015; 10: e0131854","DOI":"10.1371\/journal.pone.0131854"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Iwaki T, Arakawa T, Sandoval-Cooper MJ, Smith DL, Donahue D, Ploplis VA, Umemura K, Castellino FJ: Plasminogen Deficiency Significantly Reduces Vascular Wall Disease in a Murine Model of Type IIa Hypercholesterolemia. Biomedicines, 2021; 9","DOI":"10.3390\/biomedicines9121832"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Sanda T, Yoshimura M, Hyodo K, Ishii H, Yamashita T: Effects of long-term thrombin inhibition (dabigatran etexilate) on spontaneous thrombolytic activity during the progression of atherosclerosis in ApoE(-\/-)-LDLR(-\/-) double-knockout mice. Korean Circ J, 2020; 50: 804-816","DOI":"10.4070\/kcj.2020.0055"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Hyodo.K, Ishii. H, Yamashita. T: Effect of Edoxaban, F-Xa-Directed Oral Anticoagulant on Spontaneous Thrombolytic Activity in Apoe-\/- and Ldlr-\/- Double Knockout Mice. Int J Clinl Cardiol, 2022; 9:272","DOI":"10.23937\/2378-2951\/1410272"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Okada Y, Tsuda Y, Tada M, Wanaka K, Okamoto U, Hijikata-Okunomiya A, Okamoto S: Development of potent and selective plasmin and plasma kallikrein inhibitors and studies on the structure-activity relationship. Chem Pharm Bull (Tokyo), 2000; 48: 1964-1972","DOI":"10.1248\/cpb.48.1964"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Okamoto S, Sato S, Takada Y, Okamoto U: An Active Stereo-Isomer (Trans-Form) of Amcha and Its Antifibrinolytic (Antiplasminic) Action in Vitro and in Vivo. Keio J Med, 1964; 13: 177-185","DOI":"10.2302\/kjm.13.177"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Salama Y, Takahashi S, Tsuda Y, Okada Y, Hattori K, Heissig B: YO2 Induces Melanoma Cell Apoptosis through p53-Mediated LRP1 Downregulation. Cancers (Basel), 2022; 15","DOI":"10.3390\/cancers15010288"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Vijayashree R, Aruthra P, Rao KR: A comparison of manual and automated methods of quantitation of oestrogen\/progesterone receptor expression in breast carcinoma. J Clin Diagn Res, 2015; 9: EC01-05","DOI":"10.7860\/JCDR\/2015\/12432.5628"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Flusty B, de Havenon A, Prabhakaran S, Liebeskind DS, Yaghi S: Intracranial Atherosclerosis Treatment: Past, Present, and Future. Stroke, 2020; 51: e49-e53","DOI":"10.1161\/STROKEAHA.119.028528"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Okada Y, Tsuda Y, Wanaka K, Tada M, Okamoto U, Okamoto S, Hijikata-Okunomiya A, Bokonyi G, Szende B, Keri G: Development of plasmin and plasma kallikrein selective inhibitors and their effect on M1 (melanoma) and HT29 cell lines. Bioorg Med Chem Lett, 2000; 10: 2217-2221","DOI":"10.1016\/S0960-894X(00)00431-5"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Wu TB, Orfeo T, Moore HB, Sumislawski JJ, Cohen MJ, Petzold LR: Computational model of tranexamic acid on urokinase-mediated fibrinolysis. PLoS One, 2020; 15: e0233640","DOI":"10.1371\/journal.pone.0233640"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Iftikhar A, Mahmood N, Rabbani SA: The Urokinase-Type Plasminogen Activator Receptor (uPAR) as a Mediator of Physiological and Pathological Processes: Potential Therapeutic Strategies. Cancers (Basel), 2025; 17","DOI":"10.3390\/cancers17203309"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Lacroix R, Sabatier F, Mialhe A, Basire A, Pannell R, Borghi H, Robert S, Lamy E, Plawinski L, Camoin-Jau L, Gurewich V, Angles-Cano E, Dignat-George F: Activation of plasminogen into plasmin at the surface of endothelial microparticles: a mechanism that modulates angiogenic properties of endothelial progenitor cells in vitro. Blood, 2007; 110: 2432-2439","DOI":"10.1182\/blood-2007-02-069997"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Masato Yuasa BHYG JGS: The Fibrinolytic System and Tissue Repair (Bone and Muscle Formation). Jpn J Thromb Hemost, 2020; 31:373-380","DOI":"10.2491\/jjsth.31.373"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Pins GD, Collins-Pavao ME, Van De Water L, Yarmush ML, Morgan JR: Plasmin triggers rapid contraction and degradation of fibroblast-populated collagen lattices. J Invest Dermatol, 2000; 114: 647-653","DOI":"10.1046\/j.1523-1747.2000.00858.x"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Lijnen HR: Extracellular proteolysis in the development and progression of atherosclerosis. Biochem Soc Trans, 2002; 30: 163-167","DOI":"10.1042\/bst0300163"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Dellas C, Schremmer C, Hasenfuss G, Konstantinides SV, Schafer K: Lack of urokinase plasminogen activator promotes progression and instability of atherosclerotic lesions in apolipoprotein E-knockout mice. Thromb Haemost, 2007; 98: 220-227","DOI":"10.1160\/TH06-09-0508"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Lugano R, Pena E, Badimon L, Padro T: Aggregated low-density lipoprotein induces impairment of cytoskeleton dynamics through urokinase-type plasminogen activator\/urokinase-type plasminogen activator receptor in human vascular smooth muscle cells. J Thromb Haemost, 2012; 10: 2158-2167","DOI":"10.1111\/j.1538-7836.2012.04896.x"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Munakata S, Tashiro Y, Nishida C, Sato A, Komiyama H, Shimazu H, Dhahri D, Salama Y, Eiamboonsert S, Takeda K, Yagita H, Tsuda Y, Okada Y, Nakauchi H, Sakamoto K, Heissig B, Hattori K: Inhibition of plasmin protects against colitis in mice by suppressing matrix metalloproteinase 9-mediated cytokine release from myeloid cells. Gastroenterology, 2015; 148: 565-578 e564","DOI":"10.1053\/j.gastro.2014.12.001"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Barrett CD, Moore HB, Kong YW, Chapman MP, Sriram G, Lim D, Moore EE, Yaffe MB: Tranexamic acid mediates proinflammatory and anti-inflammatory signaling via complement C5a regulation in a plasminogen activator-dependent manner. J Trauma Acute Care Surg, 2019; 86:101-107","DOI":"10.1097\/TA.0000000000002092"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Foley JH, Walton BL, Aleman MM, O\u2019Byrne AM, Lei V, Harrasser M, Foley KA, Wolberg AS, Conway EM: Complement Activation in Arterial and Venous Thrombosis is Mediated by Plasmin. EBioMedicine, 2016; 5: 175-182","DOI":"10.1016\/j.ebiom.2016.02.011"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Schuliga M: Inflammatory actions of coagulant and fibrinolytic proteases in disease. Mediators Inflamm, 2015; 2015: 437695","DOI":"10.1155\/2015\/437695"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Wohlfart P, Xu H, Endlich A, Habermeier A, Closs EI, Hubschle T, Mang C, Strobel H, Suzuki T, Kleinert H, Forstermann U, Ruetten H, Li H: Antiatherosclerotic effects of small-molecular-weight compounds enhancing endothelial nitric-oxide synthase (eNOS) expression and preventing eNOS uncoupling. J Pharmacol Exp Ther, 2008; 325: 370-379","DOI":"10.1124\/jpet.107.128009"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Sugimoto MA, Ribeiro ALC, Costa BRC, Vago JP, Lima KM, Carneiro FS, Ortiz MMO, Lima GLN, Carmo AAF, Rocha RM, Perez DA, Reis AC, Pinho V, Miles LA, Garcia CC, Teixeira MM, Sousa LP: Plasmin and plasminogen induce macrophage reprogramming and regulate key steps of inflammation resolution via annexin A1. Blood, 2017; 129: 2896-2907","DOI":"10.1182\/blood-2016-09-742825"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Obata Y, Takeuchi K, Wei J, Hakamata A, Odagiri K, Nakajima Y, Watanabe H: Interactions between bradykinin and plasmin in the endothelial Ca(2+) response. Mol Cell Biochem, 2018; 445: 179-186","DOI":"10.1007\/s11010-017-3263-y"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Wang Q, Shao G, Zhao X, Wong HH, Chin K, Zhao M, Bai A, Bloom MS, Love ZZ, Chu CR, Cheng Z, Robinson WH: Dysregulated fibrinolysis and plasmin activation promote the pathogenesis of osteoarthritis. JCI Insight, 2024; 9","DOI":"10.1172\/jci.insight.173603"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/advpub\/0\/advpub_66328\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T04:56:11Z","timestamp":1792212971000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/advpub\/0\/advpub_66328\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":32,"URL":"https:\/\/doi.org\/10.5551\/jat.66328","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"66328"}}